MarketAnalysisMarketAnalysis
NYSE:CVS

CVS Health Corporation - NYSE:CVS - Comprehensive analysis

Free evaluation through quantitative algorithms CVS Health Corporation - NYSE:CVS

Quant Rating

1

Strong Sell

2

Sell

3

Hold

4

Buy

5

Strong Buy


The overall quant rating is not an average of the factor grades listed.Instead, it gives greater weight to the metrics with the strongest predictive value.

Growth-Scoring Model Detail

Name

Fatcor
Percentage

Total Revenue Growth Over Prior Year

3.93

Market

47

Sector

53

Gross Profit Growth Over Prior Year

-7.56

Market

10

Sector

12

EBITDA Growth Over Prior Year

-31.58

Market

5

Sector

8

EBITA Growth Over Prior Year

-37.14

Market

5

Sector

8

EBIT Growth Over Prior Year

-43.02

Market

4

Sector

8

Earnings from Cont. Ops. Growth Over Prior Year

-45.2

Market

8

Sector

12

Net Income Growth Over Prior Year

-44.7

Market

10

Sector

12

Normalized Net Income Growth Over Prior Year

-42.08

Market

5

Sector

7

Diluted EPS before Extra Growth Over Prior Year

-43.43

Market

9

Sector

10

A/R Growth Over Prior Year

-6.47

Market

17

Sector

19

Inventory Growth Over Prior Year

0.45

Market

67

Sector

73

PPE Net Growth Over Prior Year

-4.92

Market

16

Sector

47

Total Assets Growth Over Prior Year

1.4

Market

41

Sector

54

Tangible Book Value Growth Over Prior Year

0

Market

0

Sector

0

Common Equity Growth Over Prior Year

-1.18

Market

30

Sector

52

Cash from Ops. Growth Over Prior Year

-32.17

Market

9

Sector

15

CAPEX Growth Over Prior Year

-8.25

Market

25

Sector

43

Dividend per Share Growth Over Prior Year

9.92

Market

80

Sector

98

Levered Free Cash Flow Growth Over Prior Year

-37.62

Market

11

Sector

17

Unlevered Free Cash Flow Growth Over Prior Year

-31.24

Market

13

Sector

17

Profitability-Scoring Model Detail

Name

Fatcor
Percentage

Gross Margin %

13.29

Market

11

Sector

30

SG&A Margin %

11.12

Market

42

Sector

27

EBITDA Margin %

3.4

Market

4

Sector

62

EBITA Margin %

2.71

Market

10

Sector

64

EBIT Margin %

2.16

Market

4

Sector

65

Earnings from Cont. Ops Margin %

1.24

Market

6

Sector

72

Net Income Margin %

1.24

Market

6

Sector

72

Net Income Avail. for Common Margin %

1.24

Market

6

Sector

73

Normalized Net Income Margin %

1.22

Market

4

Sector

70

Levered Free Cash Flow Margin %

1.86

Market

25

Sector

64

Unlevered Free Cash Flow Margin %

2.36

Market

24

Sector

62

Return on Assets %

1.99

Market

15

Sector

73

Return on Capital %

3.19

Market

17

Sector

74

Return on Equity %

6.02

Market

14

Sector

80

Return on Common Equity %

6.07

Market

15

Sector

80

Total Asset Turnover

1.47

Market

93

Sector

96

Sub-Scoring Model

Valuation
Momentum
Growth
Profitability
80
60
40
20
Valuation: 74
Momentum: 79
Growth: 22
Profitability: 18

Valuation-Scoring Model Detail

Name

Fatcor
Percentage

TEV/LTM Total Revenue

0.42

Market

3

Sector

8

TEV/LTM EBITDA

9.31

Market

22

Sector

32

P/LTM Normalized EPS

15.86

Market

15

Sector

25

P/BV

1.11

Market

7

Sector

32

TEV/LTM Unlevered FCF

18.73

Market

27

Sector

50

Momentum-Scoring Model Detail

Name

Fatcor
Percentage

1M Price Performance

12.36

Market

97

Sector

68

3M Price Performance

3.77

Market

61

Sector

66

6M Price Performance

23.6

Market

95

Sector

87

9M Price Performance

22.8

Market

83

Sector

82

1Y Price Performance

14.86

Market

60

Sector

79

Start analyzing CVS Health Corporation - NYSE:CVS with easy-to-understand research reports

Start analyzing Recent popular companies with easy-to-understand research reports